血友病治疗市场基于(主要地区、市场参与者、规模和份额)- 预测至 2031 年

  • Report Code : TIPRE00008241
  • Category : Pharmaceuticals
  • Status : Data Released
  • No. of Pages : 150
Buy Now

2021年血友病治疗市场规模为144.4亿美元,预计将从2023年的XX亿美元增至2031年的235.3亿美元。预计2023-2031年该市场的复合年增长率为5.1%。基于 AAV(腺相关病毒)的基因疗法是血友病的一种新疗法,很可能仍然是血友病治疗市场的关键趋势。

 

血友病治疗市场分析

该市场主要由众多参与者和处于管道阶段的各种产品的存在推动。血友病治疗研发研究的增加、目标人群的增加以及血友病的患病率促进了血友病治疗市场的增长。此外,人们对血友病的认识不断提高,政府对新生儿早期识别的资助不断增加,预计将推动市场增长。

 

血友病治疗市场概述

血友病是一种遗传性出血性疾病,凝血因子有缺陷或缺乏,导致内出血和外出血。血友病治疗产品的重大技术进步为人群中的血友病管理提供了增强的治疗替代方案。随着全球目标人群的增长和诊断程序数量的增加,对新的血友病治疗方案的需求也在增加。

 

定制研究以满足您的要求

我们可以优化和定制我们的标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

血友病治疗市场:

血友病治疗市场

  • 年均复合增长率(2023 - 2031)
    5.1%
  • 2021 年市场规模
    144.4 亿美元
  • 2031 年市场规模
    235.3 亿美元

市场动态

增长动力
  • 政府积极举措的增加导致血友病患病率增加
未来的趋势
  • 研究活动和产品创新
机会
  • 血友病的新治疗方法

关键人物;主力;重要一员

  • 拜耳公司,
  • 赛诺菲,
  • F.霍夫曼拉罗氏有限公司,
  • 凯德里恩水疗中心,
  • CSL有限公司,
  • 生物测试公司,
  • 辉瑞公司,
  • 诺和诺德公司,
  • 奥克塔制药公司,
  • 百特国际公司,

区域概况

  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

产品
  • 血浆衍生凝血因子浓缩物
  • 重组凝血因子浓缩物
  • 去氨加压素
  • 抗纤维蛋白溶解剂
疾病
  • 甲型血友病
  • 乙型血友病
  • 丙型血友病
治疗类型
  • 一经请求
  • 预防
治疗
  • 替代疗法
  • ITI疗法
  • 基因治疗
  • 抗体治疗
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

血友病治疗市场驱动因素和机遇

 

有利于市场增长的有利政府举措的增加

预计多项政府举措的增加将在预测期内促进医疗保健行业的增长。世界血友病组织等组织和一些国家的政府开展了意识和诊断计划。例如,卫生资源和服务管理局 (HRSA) 妇幼保健局 (MCHB) 在 HRSA 的资助下,血友病治疗中心 (HTC) 提供重要、完整的多学科设施,例如物理治疗费用、社会工作和医疗服务。不包含在保险中的案件管理服务。政府改善公共卫生和治疗贫困人群的努力将促进血友病治疗市场的增长。

 

研究活动和产品创新

在过去五年中,开发了许多目前在多个学科中使用的血友病治疗产品。例如,2020年2月,诺和诺德推出了一种抗血友病产品Esperoct,以减少A型血友病成人和儿童的血友病影响。

 

血友病治疗市场报告细分分析

有助于血友病治疗市场分析的关键部分是产品、疾病、治疗类型、疗法和最终用户。

  • 根据产品,血友病治疗市场分为血浆衍生凝血因子浓缩物、重组凝血因子浓缩物、去氨加压素和抗纤维蛋白溶解剂。根据血浆衍生凝血因子浓缩物,市场进一步分为因子 VIII、因子 IX、因子 XII、活化凝血酶原复合物浓缩物和冯维勒布兰德因子。重组凝血因子浓缩片段进一步分为因子VIII和因子IX。血浆衍生凝血因子浓缩物细分市场在 2023 年占据更大的市场份额。
  • 按疾病划分,市场分为血友病 A、血友病 B 和血友病 C。2023 年,血友病 A 细分市场占据最大份额。
  • 就治疗类型而言,市场分为按需治疗和预防治疗。预防用药领域在 2023 年占据市场主导地位。
  • 在治疗方面,市场分为替代疗法、ITI疗法、基因疗法和抗体疗法。预防用药领域在 2023 年占据市场主导地位。
  • 按最终用户划分,市场分为医院和诊所、血友病治疗中心和门诊手术中心。 2023 年,医院和诊所细分市场占据最大市场份额。

 

按地域划分的血友病治疗市场份额分析

血友病治疗市场报告的地理范围主要分为五个地区:北美、亚太地区、欧洲、中东和非洲、南美洲和中美洲。

北美主导了血友病治疗市场。该地区外科手术数量的增加、医疗保健基础设施的改善以及技术进步的可用性等因素正在导致北美血友病治疗市场的增长。  

 

血友病治疗市场报告范围

报告属性细节
2021年市场规模144.4亿美元
2031 年市场规模235.3亿美元
全球复合年增长率(2023 - 2031)5.1%
历史数据2021-2022
预测期2023-2031
涵盖的细分市场按产品分类
  • 血浆衍生凝血因子浓缩物
  • 重组凝血因子浓缩物
  • 去氨加压素
  • 抗纤维蛋白溶解剂
按疾病分类
  • 甲型血友病
  • 乙型血友病
  • 丙型血友病
按治疗类型
  • 一经请求
  • 预防
通过治疗
  • 替代疗法
  • ITI疗法
  • 基因治疗
  • 抗体治疗
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 拜耳公司,
  • 赛诺菲,
  • F.霍夫曼拉罗氏有限公司,
  • 凯德里恩水疗中心,
  • CSL有限公司,
  • 生物测试公司,
  • 辉瑞公司,
  • 诺和诺德公司,
  • 奥克塔制药公司,
  • 百特国际公司,
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

血友病治疗市场新闻和最新动态

血友病治疗市场是通过收集初级和二级研究后的定性和定量数据来评估的,其中包括重要的公司出版物、协会数据和数据库。以下是血友病治疗市场的进展列表:

  • 日本厚生劳动省 (MHLW) 已授予 ALTUVIIIO [抗血友病因子(重组),Fc-VWF-XTEN 融合蛋白] 的营销授权,这是一种一流的高持续因子 VIII 替代疗法。 ALTUVIIIO 适用于控制 A 型血友病(VIII 因子缺乏)患者的出血倾向。 ALTUVIIIO 最近还于 2023 年 8 月 31 日获得台湾食品药品监督管理局批准用于治疗 A 型血友病成人和儿童。(来源:赛诺菲,新闻稿,2023 年)
  • 武田药品工业株式会社(“武田”)宣布在美国推出 ADYNOVATE [抗血友病因子(重组),聚乙二醇化] 的 myPKFiT,这是一款基于网络的软件和移动应用程序,是第一个也是唯一一个获得 FDA 批准的药代动力学 (PK) 给药软件美国食品和药物管理局 (FDA) 对 12 岁及以上且体重至少 29 公斤的 A 型血友病患者使用 ADYNOVATE 进行治疗。 (资料来源:武田药品工业株式会社,新闻稿,2020 年)

 

血友病治疗市场报告的范围和交付成果

《血友病治疗市场规模和预测(2021-2031)》报告对涵盖以下领域的市场进行了详细分析:

  • 范围内涵盖的所有关键细分市场的全球、区域和国家层面的市场规模和预测
  • 市场动态,例如驱动因素、限制因素和关键机遇
  • 未来主要趋势
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 全球和区域市场分析,涵盖主要市场趋势、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者和最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports